Radiolabel Study In Healthy Volunteers For Insomnia-Targeting Drug
NCT00520663
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
Sleep Initiation and Maintenance Disorders
Interventions
DRUG:
14C-SB649868
Sponsor
GlaxoSmithKline